These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11870809)
1. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach. Matsuyama Y Stat Med; 2002 Mar; 21(5):675-87. PubMed ID: 11870809 [TBL] [Abstract][Full Text] [Related]
2. A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance. Sato T Stat Med; 2001 Sep 15-30; 20(17-18):2761-74. PubMed ID: 11523081 [TBL] [Abstract][Full Text] [Related]
3. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921 [TBL] [Abstract][Full Text] [Related]
4. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. Ohno R; Miyawaki S; Hatake K; Kuriyama K; Saito K; Kanamaru A; Kobayashi T; Kodera Y; Nishikawa K; Matsuda S; Yamada O; Omoto E; Takeyama H; Tsukuda K; Asou N; Tanimoto M; Shiozaki H; Tomonaga M; Masaoka T; Miura Y; Takaku F; Ohashi Y; Motoyoshi K J Clin Oncol; 1997 Aug; 15(8):2954-65. PubMed ID: 9256140 [TBL] [Abstract][Full Text] [Related]
5. Analysis of times to repeated events in two-arm randomized trials with noncompliance and dependent censoring. Matsui S Biometrics; 2004 Dec; 60(4):965-76. PubMed ID: 15606417 [TBL] [Abstract][Full Text] [Related]
6. Analysis of recurrent events: application to a clinical trial of colony stimulating factor with the endpoint of febrile neutropenia. Matsui S; Ohashi Y Stat Med; 1999 Sep 15-30; 18(17-18):2409-20. PubMed ID: 10474149 [TBL] [Abstract][Full Text] [Related]
7. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939 [TBL] [Abstract][Full Text] [Related]
8. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements. Lui KJ Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780 [TBL] [Abstract][Full Text] [Related]
10. Causal logistic models for non-compliance under randomized treatment with univariate binary response. Ten Have TR; Joffe M; Cary M Stat Med; 2003 Apr; 22(8):1255-83. PubMed ID: 12687654 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia. Ohno R Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078 [TBL] [Abstract][Full Text] [Related]
12. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach by Yutaka Matsuyama, Statistics in Medicine 2002; 21:675-687. Lui KJ Stat Med; 2007 Nov; 26(25):4679-83. PubMed ID: 17278185 [No Abstract] [Full Text] [Related]
13. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Bohlius J; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474 [TBL] [Abstract][Full Text] [Related]
14. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements. Lui KJ; Chang KC J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis. Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524 [No Abstract] [Full Text] [Related]
16. Correction for non-compliance in equivalence trials. Robins JM Stat Med; 1998 Feb; 17(3):269-302; discussion 387-9. PubMed ID: 9493255 [TBL] [Abstract][Full Text] [Related]
17. Stratified exact tests for the weak causal null hypothesis in randomized trials with a binary outcome. Chiba Y Biom J; 2017 Sep; 59(5):986-997. PubMed ID: 28605047 [TBL] [Abstract][Full Text] [Related]
18. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors. Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials. Wittman B; Horan J; Lyman GH Cancer Treat Rev; 2006 Jun; 32(4):289-303. PubMed ID: 16678350 [TBL] [Abstract][Full Text] [Related]
20. Estimating the causal effect of compliance on binary outcome in randomized controlled trials. Goetghebeur E; Molenberghs G; Katz J Stat Med; 1998 Feb; 17(3):341-55. PubMed ID: 9493258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]